LONDON: Rainbow Rare Earths said Tuesday its board has initiated a process to evaluate the potential benefits of listing its shares on a U.S. stock exchange, citing growing North American investor demand and the country’s leadership in building out independent rare earths supply chains.
The company, which is developing rare earths recovery projects in South Africa and Brazil, said it remains focused on delivering a definitive feasibility study for its Phalaborwa project in South Africa in 2026 and launching a pre-feasibility study for its Uberaba project in Brazil. The Uberaba work is being conducted in partnership with The Mosaic Company, a U.S.-based fertilizer producer.
Rainbow said several factors drove the decision to explore a U.S. listing, including its potential to supply critical rare earth raw materials to Western supply chains, its growing ties to the U.S. through the Mosaic partnership, and continued support from the U.S. International Development Finance Corp., which holds a $50 million option to provide project equity financing for Phalaborwa.
The company noted that its recent private placement was supported predominantly by U.S.-based investors, including Traxys, a key partner in the U.S. government’s $12 billion critical raw materials stockpiling initiative known as “Project Vault.”
Rainbow plans to engage with existing shareholders and other stakeholders to solicit feedback on the potential listing and will update the market following that process. The company recovers rare earth elements from phosphogypsum, a byproduct of fertilizer production, an approach it says avoids traditional mining and allows for faster, lower-cost project development.
EDITOR’S COMMENTARY: This announcement reads less like a definitive strategic shift and more like a trial balloon wrapped in a press release. Rainbow is smart to gauge U.S. investor appetite—given Washington’s multibillion-dollar push to onshore critical mineral supply chains, a U.S. listing could unlock meaningful valuation and liquidity. But the phrase “evaluating the potential benefits” is doing a lot of work. Notably absent: a timeline, a proposed exchange (NYSE or Nasdaq?), or any indication of regulatory hurdles. The heavy emphasis on existing U.S. ties—Traxys, DFC, Mosaic—helps build a narrative, but investors should watch for concrete next steps. For now, this is a signal of ambition, not a done deal.